CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial

A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said. #VaccinesImmunization #Coronaviruscovid-19 #Rna #Curevac #Your-feed-healthcare
https://currentindia.in/curevac-s-covid-19-vaccine-disappoints-in-clinical-trial-10088.html?utm_source=currentindia.in&utm_medium=blogger